![Laurie Keating](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 82 316 $ al 31/08/2026
Laurie Bartlett Keating was the founder of Hydra Biosciences, Inc., founded in 2001, and served as Chief Executive Officer from 2001 to 2012.
Ms. Keating currently holds the positions of Chairman at PepGen Inc. since 2021, Director at Boston Public Library Foundation, Independent Director at Immuneering Corp.
since 2021, and Director at Kalaris Therapeutics, Inc. starting in 2026.
Former positions include Director at Massachusetts Biotechnology Council from 2005 to 2022, Independent Director at Imago BioSciences, Inc. from 2021 to 2023, Director at Imbria Pharmaceuticals, Inc. from 2019 to 2020, Secretary, Senior Vice President & General Counsel at Lenovo EMC Ltd., Secretary, Senior Vice President & General Counsel at Sybase, Inc., Secretary, Chief Legal Officer & Executive Vice President at Alnylam Pharmaceuticals, Inc. from 2019 to 2021, and Secretary, Senior Vice President & General Counsel at Millennium Pharmaceuticals, Inc. from 2010 to 2014.
Education includes undergraduate studies at the University of California, Berkeley, and graduate studies at the University of California, Hastings.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 11/06/2026 | 14.000 ( 0,02 % ) | 69 860 $ | 31/08/2026 | |
PEPGEN INC. 0,01 % | 18/06/2026 | 4.166 ( 0,01 % ) | 12 456 $ | 31/08/2026 |
-.--% | 01/08/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| IMMUNEERING CORPORATION | Director/Miembro de la Junta | 27/04/2021 |
| PEPGEN INC. | Presidente | 01/12/2021 |
Boston Public Library Foundation
 Boston Public Library Foundation Investment Trusts/Mutual FundsMiscellaneous Engages in raising public and private funds for Boston public library | Director/Miembro de la Junta | 01/04/2011 |
| Empresas | Cargo | Fin |
|---|---|---|
| IMAGO BIOSCIENCES, INC. | Director/Miembro de la Junta | 11/01/2023 |
Massachusetts Biotechnology Council
 Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Operates as an association of biotechnology companies | Director/Miembro de la Junta | 01/03/2022 |
| ALNYLAM PHARMACEUTICALS, INC. | Consejero General | 10/09/2021 |
Imbria Pharmaceuticals, Inc.
 Imbria Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage company for the treatment of cardiovascular disease | Director/Miembro de la Junta | 01/01/2020 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Consejero General | 01/01/2014 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 13 |
|---|---|
Lenovo EMC Ltd.
 Lenovo EMC Ltd. Computer PeripheralsElectronic Technology Manufactures, designs, and markets data storage devices | Electronic Technology |
Sybase, Inc.
 Sybase, Inc. Packaged SoftwareTechnology Services Operates as an enterprise software and services company | Technology Services |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Alnylam Pharmaceuticals, Inc.
 Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hydra Biosciences, Inc.
 Hydra Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops molecular regeneration medicines to treat pain, inflammation, anxiety and other diseases | Health Technology |
Massachusetts Biotechnology Council
Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Operates as an association of biotechnology companies | Commercial Services |
University of California, Hastings
 University of California, Hastings Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boston Public Library Foundation
Boston Public Library Foundation Investment Trusts/Mutual FundsMiscellaneous Engages in raising public and private funds for Boston public library | Miscellaneous |
Immuneering Corp.
 Immuneering Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, focuses on the oncology and neuroscience product candidates | Health Technology |
Imago BioSciences, Inc.
 Imago BioSciences, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops medicines for the treatment of myeloproliferative neoplasms and bone marrow diseases | Health Technology |
Imbria Pharmaceuticals, Inc.
Imbria Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage company for the treatment of cardiovascular disease | Commercial Services |
PepGen Inc.
 PepGen Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company which develops oligonucleotide therapeutics for treatment of severe neuromuscular and neurologic diseases | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
